BLOG

NK Cell Therapy After Cancer Treatment: Questions to Ask in Osaka

Published 2026.10.16 8 min read

Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.

Finishing surgery, chemotherapy or radiation therapy is a milestone, but many people then ask a new question: is there anything else worth considering to support the body afterward? Some patients come across NK cell therapy, an immune cell therapy that uses a patient’s own natural killer cells. This article explains how NK cell therapy is described in the context of recurrence prevention and immune maintenance, what its limits are, and which questions to bring to a doctor at Grand Green Osaka Umekita Clinic or any other medical institution.

The short answer: an option to discuss, not a replacement for follow-up care

NK cell therapy is sometimes used after standard cancer treatment with the aim of supporting immune function and helping to reduce the chance of recurrence. It is important to be clear about what this means. It is not a substitute for surgery, drug therapy, radiation or regular follow-up examinations with your oncologist, and no result can be promised for any individual. Whether it is appropriate depends on your cancer type, stage, treatment history, current health and preferences, and that judgment needs to be made by a doctor after a consultation.

At Grand Green Osaka Umekita Clinic in Osaka, the therapy is provided as a self-pay (not covered by national health insurance) treatment. Costs, number of sessions, risks and possible side effects should all be confirmed with a physician before any decision is made.

Why recurrence is a concern and where NK cells fit in

Even after treatment that appears successful, some people worry that a small number of cancer cells may remain undetected. The immune system is thought to play a role in recognizing and removing abnormal cells, a process often called immune surveillance. Natural killer (NK) cells are a type of innate immune cell that can recognize and attack abnormal cells without needing instructions from other immune cells.

It is also known that NK cell activity can decline with age, stress and the effects of cancer itself. This observation is the basis for the idea of returning a larger number of activated NK cells to the body. Laboratory and early clinical research has explored this approach, but the available findings vary by cancer type and study design, and a single study should not be taken as proof that the approach works for everyone. If you want to read the research yourself, PubMed is a useful public database, and your doctor can help you interpret what you find.

How the treatment process works

In NK cell therapy, a standard blood sample is taken from the patient. The cells are then activated and expanded at a specialized cell processing facility, and the resulting NK cells are returned to the patient by intravenous infusion. Because the cells come from the patient, this is called an autologous therapy. The treatment does not require hospitalization, and many patients are able to continue daily life during the treatment period, although this depends on individual circumstances.

Because the therapy uses the patient’s own cells, the risk of rejection is considered low, and serious side effects have rarely been reported. However, temporary reactions such as fever or fatigue can occur, and no treatment is free of risk. Ask the clinic to explain what reactions have been observed, how they are handled, and what to do if symptoms appear after you return home or travel back to your own country.

Using NK cell therapy alongside standard care

NK cell therapy is described as not interfering with surgery, chemotherapy or radiation therapy, which means it can be considered alongside them. For someone who has finished standard treatment, the more practical question is how it would fit with your follow-up plan. Regular imaging, blood tests and visits with your oncologist remain the foundation of monitoring for recurrence.

Grand Green Osaka Umekita Clinic can coordinate with the medical institution that provides your standard treatment. If you are considering this therapy, it is wise to tell your oncologist about your plan, share your treatment records, and ask whether there is any reason to adjust the timing. Combining information from both doctors usually leads to better-informed decisions than relying on one source alone.

Questions to ask before you decide

A consultation is most useful when you arrive prepared. The following questions can help you understand both the potential and the limits of the therapy for your situation.

Based on my cancer type, stage and treatment history, is NK cell therapy something a doctor would recommend considering, and why or why not?
What is the purpose of the therapy in my case, and how will progress be reviewed over time?
What are the known risks and possible side effects, and what happens if I experience them?
What is the total cost, including consultation, blood collection, cell culture and each infusion, and how many sessions are usually planned?
Where are the cells processed, and how is the treatment managed under Japanese regulations?
How will the clinic communicate with my current oncologist, and can records be shared in English?

Regulation, cost and information for international patients

In Japan, treatments that use cells are provided under the Act on the Safety of Regenerative Medicine. Clinics submit a provision plan that is reviewed by a certified committee and then filed with the Ministry of Health, Labour and Welfare, and cell processing takes place at licensed facilities. This framework addresses quality and oversight, but it does not mean that a treatment has been shown to be effective for every patient. Because the therapy is outside national health insurance, patients bear the full cost, and it is reasonable to request a written estimate before starting.

For overseas patients and international residents, planning matters. Think about how many visits to Osaka may be required, how follow-up will be handled after you return home, and whether your home doctor can receive reports. The clinic in Umeda offers information pages in multiple languages, and you can start by reading them and preparing your questions before contacting the clinic.

Summary

NK cell therapy is an immune cell therapy that some patients consider after standard cancer treatment, with the aim of supporting immune function and reducing the chance of recurrence. It uses your own cells, requires only a blood draw and intravenous infusion, and is provided in Japan under a regulatory framework. At the same time, it is a self-pay treatment, outcomes differ between individuals, and it does not replace standard treatment or regular check-ups. The most reliable next step is a consultation with a doctor, where your records, risks, costs and goals can be reviewed together, ideally with input from your own oncologist.

NK Cell Therapy After Treatment

Not a replacementFollow-up care continues
Your own NK cellsBlood draw and IV infusion
Ask before decidingRisks, costs, sessions
Talk to your doctorsCoordinate with oncologist

This figure is a conceptual summary of the article content

Learn more about NK Cell Therapy

References

Supervising Physician

Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic

Hidenori Shimada

Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.

* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.

Back to article list › Back to NK Cell Therapy ›